TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has received notification of the issuance of Canadian patent number 2877729 for “Nuclease Protection Methods for Detection of Nucleotide Variants.” The patented technology involves a nuclease protection method using wildtype […]
— VUI-202012/01 Variant May Increase SARS-CoV-2 Transmissibility by 70% — — Controls to be Used to Develop, Verify and Validate Tests that Identify More Transmissible Variant — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today […]
Murrieta Genomics has announced that SimplSeq, Inc., a wholly owned subsidiary, has filed its fourth patent application to protect a new sample preparation technology that is designed to simplify the process for extracting, isolating, purifying and replicating DNA and RNA from biologic samples. “Our internal validation testing has delivered some very exciting data, and we […]
Used with STRmix™, Software Enables Rapid Analysis of DNA Profiles WASHINGTON (PRWEB) December 22, 2020 FaSTR™ DNA, expert forensic software that rapidly analyzes DNA profiles and can assign a Number of Contributors (NoC) estimate, is now available commercially. The wider release of FaSTR™ DNA to the forensic and education/research community comes six months after its […]
— State-of-the-Art Site Near Portland, Oregon Expected to More than Double Manufacturing Capacity, Increase Speed of Production and Enable Enhanced Product Offerings — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced plans to expand its manufacturing […]
Edinburgh, Scotland UK Arrayjet, the Scottish-based bio-printing and microarray technology company, has announced the appointment of its new non-executive Chairman. Dr Joe Keegan, a San Francisco-based biotechnology entrepreneur and one of the most respected leaders in the global life sciences industry, will replace Edinburgh-based serial entrepreneur and business strategist Alan Faichney, who is stepping down as […]
Since its launch in 2017, Saphyr® throughput has increased by 1,400%, from a maximum of 384 human genomes per year to nearly 5,000 per year with the latest software release, representing the achievement of a goal of at least 12 genomes per day by the end of 2020 Generation 2 Saphyr instruments (those shipped since […]
HTG Announces First Collaborator in Early Access Program for its Prototype Whole Transcriptome Panel
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has signed up the first collaborator in its recently announced Early Access Program for its prototype whole transcriptome panel. The Early Access Program is intended to allow select customers access […]
The creation of a Software Development Hub for Genomic Data in Laval, Quebec, strengthens Roche Canada’s leadership in the Life Science sector. Roche Diagnostics, a division of Hoffmann-La Roche Limited, is pleased to announce that a new Software Development Hub will be housed at the Roche Diagnostics Canadian Head Office, located in the Cité de […]
New Carlsbad, California cGMP site will accelerate commercialization of plasmid-based medicines and vaccines WALTHAM, Mass. — Thermo Fisher Scientific, the world leader in serving science, today announced the construction of a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif. The site will expand the company’s clinical and commercial capabilities for cGMP plasmid DNA used as a critical […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
